Related Experiment Videos

[Antimicrobial activities of piperacillin against fresh clinically isolated strains]

K Deguchi1, N Yokota, M Koguchi

  • 1Section of Studies, Tokyo Clinical Research Center.

Insights

Antimicrobial activity of piperacillin (PIPC) remained stable, but resistance to beta-lactams is increasing in hospitals. New resistant bacterial strains, including Streptococcus pneumoniae and Escherichia coli, have emerged.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Context:

  • Evaluation of antimicrobial activity of piperacillin (PIPC) against clinically isolated bacterial strains.
  • Comparison of piperacillin's efficacy in mid-1980s versus 1994.
  • Analysis of bacterial resistance patterns in community-acquired versus general hospitals.

Purpose:

  • To determine the minimum inhibitory concentrations (MICs) of piperacillin and control agents.
  • To identify emerging beta-lactam-resistant bacterial strains.
  • To assess the prevalence of resistance in different hospital settings.

Summary:

  • Piperacillin's MIC70 values against major strains showed stability compared to the mid-1980s.
  • Bacterial resistance to beta-lactams, including piperacillin, was higher in general hospitals than in community-acquired hospitals.
  • New beta-lactam-resistant strains, such as benzylpenicillin-insensitive Streptococcus pneumoniae and beta-lactamase-producing Prevotella spp., were identified.

Impact:

  • Highlights the need for ongoing surveillance of antimicrobial resistance.
  • Informs clinical decisions regarding antibiotic use and treatment strategies.
  • Identifies specific bacterial strains and resistance mechanisms requiring further investigation.

Related Concept Videos